Vcelar B - Search Results

1

Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection.

Mehandru S, Vcelar B, Wrin T, Stiegler G, Joos B, Mohri H, Boden D, Galovich J, Tenner-Racz K, Racz P, Carrington M, Petropoulos C, Katinger H, Markowitz M. Mehandru S, et al. Among authors: vcelar b. J Virol. 2007 Oct;81(20):11016-31. doi: 10.1128/JVI.01340-07. Epub 2007 Aug 8. J Virol. 2007. PMID: 17686878 Free PMC article. Clinical Trial.

2

Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10.

Mehandru S, Wrin T, Galovich J, Stiegler G, Vcelar B, Hurley A, Hogan C, Vasan S, Katinger H, Petropoulos CJ, Markowitz M. Mehandru S, et al. Among authors: vcelar b. J Virol. 2004 Dec;78(24):14039-42. doi: 10.1128/JVI.78.24.14039-14042.2004. J Virol. 2004. PMID: 15564511 Free PMC article.

3

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.

Trkola A, Kuster H, Rusert P, Joos B, Fischer M, Leemann C, Manrique A, Huber M, Rehr M, Oxenius A, Weber R, Stiegler G, Vcelar B, Katinger H, Aceto L, Günthard HF. Trkola A, et al. Among authors: vcelar b. Nat Med. 2005 Jun;11(6):615-22. doi: 10.1038/nm1244. Epub 2005 May 8. Nat Med. 2005. PMID: 15880120 Clinical Trial.

4

Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5).

Joos B, Trkola A, Kuster H, Aceto L, Fischer M, Stiegler G, Armbruster C, Vcelar B, Katinger H, Günthard HF. Joos B, et al. Among authors: vcelar b. Antimicrob Agents Chemother. 2006 May;50(5):1773-9. doi: 10.1128/AAC.50.5.1773-1779.2006. Antimicrob Agents Chemother. 2006. PMID: 16641449 Free PMC article. Clinical Trial.

5

Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data.

Vcelar B, Stiegler G, Wolf HM, Muntean W, Leschnik B, Mehandru S, Markowitz M, Armbruster C, Kunert R, Eibl MM, Katinger H. Vcelar B, et al. AIDS. 2007 Oct 18;21(16):2161-70. doi: 10.1097/QAD.0b013e328285da15. AIDS. 2007. PMID: 18090042

6

A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1.

Armbruster C, Stiegler GM, Vcelar BA, Jäger W, Michael NL, Vetter N, Katinger HW. Armbruster C, et al. AIDS. 2002 Jan 25;16(2):227-33. doi: 10.1097/00002030-200201250-00012. AIDS. 2002. PMID: 11807307 Clinical Trial.

7

Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12.

Armbruster C, Stiegler GM, Vcelar BA, Jäger W, Köller U, Jilch R, Ammann CG, Pruenster M, Stoiber H, Katinger HW. Armbruster C, et al. J Antimicrob Chemother. 2004 Nov;54(5):915-20. doi: 10.1093/jac/dkh428. Epub 2004 Sep 29. J Antimicrob Chemother. 2004. PMID: 15456731 Clinical Trial.

8

Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation.

Stiegler G, Armbruster C, Vcelar B, Stoiber H, Kunert R, Michael NL, Jagodzinski LL, Ammann C, Jäger W, Jacobson J, Vetter N, Katinger H. Stiegler G, et al. Among authors: vcelar b. AIDS. 2002 Oct 18;16(15):2019-25. doi: 10.1097/00002030-200210180-00006. AIDS. 2002. PMID: 12370500 Clinical Trial.

9

Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study.

Riedl CR, Sternig P, Gallé G, Langmann F, Vcelar B, Vorauer K, Wagner A, Katinger H, Pflüger H. Riedl CR, et al. Among authors: vcelar b. Eur Urol. 2005 Oct;48(4):656-61. doi: 10.1016/j.eururo.2005.04.011. Eur Urol. 2005. PMID: 15982798 Clinical Trial.

10

Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants.

Ma JK, Drossard J, Lewis D, Altmann F, Boyle J, Christou P, Cole T, Dale P, van Dolleweerd CJ, Isitt V, Katinger D, Lobedan M, Mertens H, Paul MJ, Rademacher T, Sack M, Hundleby PA, Stiegler G, Stoger E, Twyman RM, Vcelar B, Fischer R. Ma JK, et al. Among authors: vcelar b. Plant Biotechnol J. 2015 Oct;13(8):1106-20. doi: 10.1111/pbi.12416. Epub 2015 Jul 3. Plant Biotechnol J. 2015. PMID: 26147010 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page